Related Experiment Video
Updated: Aug 13, 2026
05:37
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
Valproate hepatotoxicity syndrome: hypotheses of pathogenesis
1Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle 98195.
Pharmaceutisch Weekblad. Scientific Edition
|June 19, 1992
Summary
Valproate (VPA) can cause rare but fatal liver damage, presenting as severe symptoms and histopathological changes. Current theories on its pathogenesis remain incomplete, highlighting the need for further research into this severe adverse effect.
Area of Science:
- Hepatology
- Pharmacology
- Toxicology
Background:
- Valproate (VPA) is an anticonvulsant medication.
- VPA use is linked to rare, severe, and potentially fatal hepatotoxicity.
- Clinical presentation includes lethargy, anorexia, vomiting, and coma.
Purpose of the Study:
- To review the characteristics of VPA-induced hepatotoxicity.
- To discuss postulated hypotheses regarding the pathogenesis of VPA hepatotoxicity.
- To highlight the limitations of current explanations for VPA-induced liver injury.
Main Methods:
- Literature review of VPA-induced hepatotoxicity cases.
- Analysis of clinical presentations and liver histopathology.
- Evaluation of proposed pathogenetic mechanisms.
Main Results:
- Hepatotoxicity presents with steatosis and/or necrosis.
- Rapid progression to coma can occur.
- Hypotheses involve biochemical alterations and toxic VPA metabolites (e.g., delta 4-VPA).
Conclusions:
- VPA-induced hepatotoxicity is a severe adverse effect.
- Current pathogenetic hypotheses do not fully explain the disorder's varied presentation.
- Further research is needed to elucidate the mechanisms of VPA hepatotoxicity.
More Related Videos
Related Concept Videos
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...